4. Mai 2024

BASEL JUNE 2 2013 – NOVARTIS TODAY PRESENTED RESULTS FROM A PIVOTAL PHASE III TRIAL OF A TREATMENT REGIMEN INCLUDING AFINITOR EVEROLIMUS TABLETS IN WOMEN WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 POSITIVE HER2…

Aktienkurse
Watchlist
Broker
Forum
Blogs
Serie



Zertifikatesuche

Berlin: Sonntag, den 2. Juni 2013 – 15:13:10 Uhr Quelle: ad-hoc… [weiterlesen]